mavorixafor will boost the amount or outcome of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Observe for adverse outcomes of sensitive CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).Reserve concomitant prescribing of these medication in clients for whom other treatment po